Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Drugs Acting on Autonomic Ganglia: Blockers01:28

Drugs Acting on Autonomic Ganglia: Blockers

Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acceptance and Utilization of Real-World Evidence among Cancer Care Physicians in the USA: A National Survey.

Pharmaceutical medicine·2025
Same author

Health change awareness and its association with weight loss following bariatric surgery.

Health psychology : official journal of the Division of Health Psychology, American Psychological Association·2023
Same author

Relationships Between Telomere Length, Plasma Glucagon-like Peptide 1, and Insulin in Early-Life Stress-Exposed Nonhuman Primates.

Biological psychiatry global open science·2022
Same author

Long-Term Outcomes of Bariatric Surgery in Idiopathic Intracranial Hypertension Patients.

The neurologist·2022
Same author

Obesity and breast cancer: Preventive and therapeutic possibilities for bariatric surgery.

Obesity (Silver Spring, Md.)·2022
Same author

Postbariatric hypoglycemia: symptom patterns and associated risk factors in the Longitudinal Assessment of Bariatric Surgery study.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery·2021

Related Experiment Video

Updated: Jun 21, 2026

Implantation Surgery for Abdominal Vagus Nerve Stimulation and Recording Studies in Awake Rats
07:17

Implantation Surgery for Abdominal Vagus Nerve Stimulation and Recording Studies in Awake Rats

Published on: January 19, 2024

Vagal nerve function in obesity: therapeutic implications.

John G Kral1, Wencesley Paez, Bruce M Wolfe

  • 1Department of Surgery, State University of New York Downstate Medical Center, 450 Clarkson Avenue, Box 40, Brooklyn, NY, 11203, USA. jkral@downstate.edu

World Journal of Surgery
|July 21, 2009
PubMed
Summary
This summary is machine-generated.

The vagus nerve plays a key role in regulating nutrient intake and energy balance. Interrupting vagal signals through bariatric surgery can reduce hunger and promote weight loss in patients with obesity.

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Understanding the Effects of Non-Invasive Transauricular Vagus Nerve Stimulation on EEG and HRV
04:59

Understanding the Effects of Non-Invasive Transauricular Vagus Nerve Stimulation on EEG and HRV

Published on: January 19, 2024

Related Experiment Videos

Last Updated: Jun 21, 2026

Implantation Surgery for Abdominal Vagus Nerve Stimulation and Recording Studies in Awake Rats
07:17

Implantation Surgery for Abdominal Vagus Nerve Stimulation and Recording Studies in Awake Rats

Published on: January 19, 2024

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Understanding the Effects of Non-Invasive Transauricular Vagus Nerve Stimulation on EEG and HRV
04:59

Understanding the Effects of Non-Invasive Transauricular Vagus Nerve Stimulation on EEG and HRV

Published on: January 19, 2024

Area of Science:

  • Neuroscience
  • Physiology
  • Metabolic Medicine

Background:

  • Nutrient sensing and alimentation evolved with neural complexity, involving ATP signaling and the gut-brain-gut axis.
  • The vagus nerve is central to the autonomic neurohumoral pathway integrating energy homeostasis.
  • Human overnutrition, driven by dysautonomia, overrides basic nutrient needs, leading to obesity.

Purpose of the Study:

  • To review the functional anatomy and role of the vagus nerve in chronic overnutrition.
  • To describe interventions targeting the vagus nerve to manage obesity.
  • To highlight how bariatric surgery impacts autonomic nervous system function and the brain-gut axis.

Main Methods:

  • Review of laboratory and clinical mechanistic studies.
  • Analysis of the functional anatomy of the vagus nerve.
  • Examination of bariatric surgery's effects on energy homeostasis and autonomic function.

Main Results:

  • The vagus nerve is crucial in maintaining maladaptive chronic overnutrition.
  • Bariatric operations, regardless of type, rely on autonomic nervous system regulation.
  • Interrupting vagal transmission significantly reduces hunger and promotes weight loss.

Conclusions:

  • The vagus nerve is a critical target for obesity interventions.
  • Bariatric surgery effectively circumvents overnutrition mechanisms by modulating the brain-gut axis.
  • Modulating vagal nerve activity offers a promising therapeutic strategy for obesity management.